TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T10348 XX ID T10348 XX DT 22.06.2006 (created); din. DT 17.09.2014 (updated); yre. CO Copyright (C), QIAGEN. XX FA YB-1 XX SY BP-8; CSDA2; CSDB; DbpB; MDR-NF1; MGC104858; MGC110976; MGC117250; NSEP-1; NSEP1; nuclease sensitive element binding protein 1; Y box binding protein 1; YB-1; YB1; YBX1. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G004962 YBX1; HGNC: YBX1. XX CL C0019; CSD; 9.1.1.2.1. XX IN T14205 ALY; human, Homo sapiens. IN T15204 brca1; Mammalia. IN T02853 hnRNPK; human, Homo sapiens. IN T16959 HSN3; human, Homo sapiens. IN T21984 p300; human, Homo sapiens. IN T23091 p300; Mammalia. IN T27304 PHF5A; human, Homo sapiens. XX MX M03805 V$YB1_Q3. MX M03862 V$YB1_Q4. XX BS R60541. BS R29594. BS R28381. BS R28365. BS R60151. BS R28363. BS R28298. BS R22179. BS R26760. BS R38303. BS R20809. BS R28310. BS R29245. BS R28169. BS R28170. BS R63410. BS R28318. BS R37393. BS R28374. BS R28375. BS R28376. BS R28377. BS R28378. BS R28350. BS R63819. BS R63820. BS R29381. BS R63224. BS R63226. BS R28367. BS R63218. BS R63210. BS R28387. BS R63203. BS R63221. XX DR TRANSPATH: MO000083480. DR UniProtKB: P67809; XX RN [1]; RE0048177. RX PUBMED: 9927044. RA Ise T., Nagatani G., Imamura T., Kato K., Takano H., Nomoto M., Izumi H., Ohmori H., Okamoto T., Ohga T., Uchiumi T., Kuwano M., Kohno K. RT Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. RL Cancer Res. 59:342-346 (1999). RN [2]; RE0050746. RX PUBMED: 17643122. RA Kim H., Huang J., Chen J. RT CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response. RL Nat. Struct. Mol. Biol. 14:710-715 (2007). RN [3]; RE0052485. RX PUBMED: 12674497. RA Moraes K. C., Quaresma A. J., Maehnss K., Kobarg J. RT Identification and characterization of proteins that selectively interact with isoforms of the mRNA binding protein AUF1 (hnRNP D). RL Biol. Chem. 384:25-37 (2003). RN [4]; RE0055571. RX PUBMED: 19036157. RA Stratford A. L., Fry C. J., Desilets C., Davies A. H., Cho Y. Y., Li Y., Dong Z., Berquin I. M., Roux P. P., Dunn S. E. RT Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells. RL Breast Cancer Res. 10:R99 (2008). RN [5]; RE0056036. RX PUBMED: 18974106. RA Lee C., Dhillon J., Wang M. Y., Gao Y., Hu K., Park E., Astanehe A., Hung M. C., Eirew P., Eaves C. J., Dunn S. E. RT Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice. RL Cancer Res. 68:8661-8666 (2008). RN [6]; RE0063494. RX PUBMED: 10589685. RA Mertens P. R., Alfonso-Jaume M. A., Steinmann K., Lovett D. H. RT YB-1 regulation of the human and rat gelatinase A genes via similar enhancer elements. RL J. Am. Soc. Nephrol. 10:2480-2487 (1999). RN [7]; RE0073117. RX PUBMED: 9497311. RA Ohga T., Uchiumi T., Makino Y., Koike K., Wada M., Kuwano M., Kohno K. RT Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. RL J. Biol. Chem. 273:5997-6000 (1998). XX //